相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PTP1B inhibitor alleviates deleterious microglial activation and neuronal injury after ischemic stroke by modulating the ER stress-autophagy axis via PERK signaling in microglia
Yu Zhu et al.
Aging-US (2021)
Small-Molecule Inhibitors of Shp2 Phosphatase as Potential Chemotherapeutic Agents for Glioblastoma: A Minireview
Rangan Mitra et al.
CHEMMEDCHEM (2021)
Alzheimer disease and the periodontal patient: New insights, connections, and therapies
Mark I. Ryder et al.
PERIODONTOLOGY 2000 (2021)
PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor
Satoko Koga et al.
TRANSLATIONAL ONCOLOGY (2021)
Therapeutic potential of targeting SHP2 in human developmental disorders and cancers
Dadong Shen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Neuronal Protein Tyrosine Phosphatase 1B Hastens Amyloid β-Associated Alzheimer's Disease in Mice
Konrad M. Ricke et al.
JOURNAL OF NEUROSCIENCE (2020)
A resurrection of aducanumab for Alzheimer's disease
Lon Schneider
LANCET NEUROLOGY (2020)
Dopamine response gene pathways in dorsal striatum MSNs from a gene expression viewpoint: cAMP-mediated gene networks
Vladimir N. Babenko et al.
BMC NEUROSCIENCE (2020)
Small Molecule Amyloid-β Protein Precursor Processing Modulators Lower Amyloid-β Peptide Levels via cKit Signaling
Ci-Di Chen et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Protective Effect of Hyperbaric Oxygen Therapy on Cognitive Function in Patients with Vascular Dementia
Yuzhen Xu et al.
CELL TRANSPLANTATION (2019)
Assessment of Azeliragon QTc Liability Through Integrated, Model-Based Concentration QTc Analysis
Aaron H. Burstein et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2019)
Investigational BACE inhibitors for the treatment of Alzheimer's disease
Bruno P. Imbimbo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Lifestyle and Risk Factors of Dementia in Rural West Texas
P. Hemachandra Reddy
JOURNAL OF ALZHEIMERS DISEASE (2019)
Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study A Randomized Clinical Trial
Sharon J. Sha et al.
JAMA NEUROLOGY (2019)
Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs
Mukta Agrawal et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease
Lawrence S. Honig et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Clinical efficacy and safety of donepezil in the treatment of Alzheimer's disease in Chinese patients
Nan Zhang et al.
CLINICAL INTERVENTIONS IN AGING (2018)
Structure-Based Virtual Screening of Protein Tyrosine Phosphatase Inhibitors: Significance, Challenges, and Solutions
Rallabandi Harikrishna Reddy et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2017)
GAB2 rs2373115 variant contributes to Alzheimer's disease risk specifically in European population
Yang Hu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
Human umbilical cord plasma proteins revitalize hippocampal function in aged mice
Joseph M. Castellano et al.
NATURE (2017)
Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer’s Therapy?
Marcelo N. N. Vieira et al.
Frontiers in Aging Neuroscience (2017)
Drug candidates in clinical trials for Alzheimer's disease
Shih-Ya Hung et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Combination of PKCε Activation and PTP1B Inhibition Effectively Suppresses Aβ-Induced GSK-3β Activation and Tau Phosphorylation
Takeshi Kanno et al.
MOLECULAR NEUROBIOLOGY (2016)
BDNF Induces Striatal-Enriched Protein Tyrosine Phosphatase 61 Degradation Through the Proteasome
Ana Saavedra et al.
MOLECULAR NEUROBIOLOGY (2016)
Drug treatments in Alzheimer's disease
Robert Briggs et al.
CLINICAL MEDICINE (2016)
Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease
Florence Pasquier et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Dual-specificity phosphatase 26 (DUSP26) stimulates Aβ42 generation by promoting amyloid precursor protein axonal transport during hypoxia
Sunmin Jung et al.
JOURNAL OF NEUROCHEMISTRY (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
PTEN recruitment controls synaptic and cognitive function in Alzheimer's models
Shira Knafo et al.
NATURE NEUROSCIENCE (2016)
The calpain system is associated with survival of breast cancer patients with large but operable inflammatory and non-inflammatory tumours treated with neoadjuvant chemotherapy
Sarah J. Storr et al.
ONCOTARGET (2016)
Biological and physiological role of reactive oxygen species - the good, the bad and the ugly
L. Zuo et al.
ACTA PHYSIOLOGICA (2015)
SHP2 sails from physiology to pathology
Mylene Tajan et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2015)
Mapping the SUMOylated landscape
Karolin Eifler et al.
FEBS JOURNAL (2015)
Analysis of Food Pairing in Regional Cuisines of India
Anupam Jain et al.
PLOS ONE (2015)
Dual-Specificity Phosphatases as Molecular Targets for Inhibition in Human Disease
Pablo Rios et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Effects of protein tyrosine phosphatase-PEST are reversed by Akt in T cells
Yutaka Arimura et al.
CELLULAR SIGNALLING (2014)
New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease
Miguel Medina et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
Hyperinsulinemia induces insulin resistance and immune suppression via Ptpn6/Shp1 in zebrafish
Ruben Marin-Juez et al.
JOURNAL OF ENDOCRINOLOGY (2014)
Analysis of PTP1B sumoylation
Sayanti Saha et al.
METHODS (2014)
Structural basis for extracellular cis and trans RPTPσ signal competition in synaptogenesis
Charlotte H. Coles et al.
NATURE COMMUNICATIONS (2014)
The family-wide structure and function of human dual-specificity protein phosphatases
Dae Gwin Jeong et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2014)
Dual-specificity MAP kinase phosphatases (MKPs): Shaping the outcome of MAP kinase signalling
Christopher J. Caunt et al.
FEBS JOURNAL (2013)
Protein tyrosine phosphatase structure-function relationships in regulation and pathogenesis
Frank Boehmer et al.
FEBS JOURNAL (2013)
Molecular mechanisms of neuropathological changes in Alzheimer's disease: a review
Omar Sery et al.
FOLIA NEUROPATHOLOGICA (2013)
Shp2 plays a crucial role in cell structural orientation and force polarity in response to matrix rigidity
Hsiao-Hui Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Growth hormone modulation of EGF-induced PI3K-Akt pathway in mice liver
Ma Eugenia Diaz et al.
CELLULAR SIGNALLING (2012)
The genetic association of DUSP6 with bipolar disorder and its effect on ERK activity
Se Hyun Kim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Dual-Specificity MAP Kinase Phosphatases as Targets of Cancer Treatment
Caroline Nunes-Xavier et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2011)
Short bouts of mild-intensity physical exercise improve spatial learning and memory in aging rats: Involvement of hippocampal plasticity via AKT, CREB and BDNF signaling
Aderbal S. Aguiar et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2011)
Inside the human cancer tyrosine phosphatome
Sofi G. Julien et al.
NATURE REVIEWS CANCER (2011)
Targeting Protein Tyrosine Phosphatases for Anticancer Drug Discovery
Latanya M. Scott et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development
Alastair J. Barr
FUTURE MEDICINAL CHEMISTRY (2010)
Akt promotes chemoresistance in human ovarian cancer cells by modulating cisplatin-induced, p53-dependent ubiquitination of FLICE-like inhibitory protein
M. R. Abedini et al.
ONCOGENE (2010)
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Florent Ginhoux et al.
SCIENCE (2010)
Sequence-specific 1HN, 13C, and 15N backbone resonance assignments of the 34 kDa Paramecium bursaria Chlorella virus 1 (PBCV1) DNA ligase
Andrea Piserchio et al.
BIOMOLECULAR NMR ASSIGNMENTS (2009)
Protein tyrosine phosphatase SHP-2: A proto-oncogene product that promotes Ras activation
Takashi Matozaki et al.
CANCER SCIENCE (2009)
Large-Scale Structural Analysis of the Classical Human Protein Tyrosine Phosphatome
Alastair J. Barr et al.
CELL (2009)
Structural Flexibility and Interactions of PTP1B's S-Loop
Jing-Fang Wang et al.
INTERDISCIPLINARY SCIENCES-COMPUTATIONAL LIFE SCIENCES (2009)
The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway
Marie Dance et al.
CELLULAR SIGNALLING (2008)
Protein tyrosine phosphatases: structure-function relationships
Lydia Tabernero et al.
FEBS JOURNAL (2008)
The Tyrosine Phosphatase STEP Mediates AMPA Receptor Endocytosis after Metabotropic Glutamate Receptor Stimulation
Yang Zhang et al.
JOURNAL OF NEUROSCIENCE (2008)
GAB2 alleles modify Alzheimer's risk in APOE ε4 carriers
Eric M. Reiman et al.
NEURON (2007)
Caspase-3 regulates catalytic activity and scaffolding functions of the protein tyrosine phosphatase PEST, a novel modulator of the apoptotic response
Maxime Halle et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Crystal structure of the catalytic domain of human DUSP5, a dual specificity MAP kinase protein phosphatase
Dae Gwin Jeong et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)
Regulation of protein tyrosine phosphatase 1B by sumoylation
Shrikrishna Dadke et al.
NATURE CELL BIOLOGY (2007)
Protein tyrosine phosphatases: from genes, to function, to disease
Nicholas K. Tonks
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
MAPK-specific tyrosine phosphatases: new targets for drug discovery?
Alastair J. Barr et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Regulation of NMDA receptor trafficking and function by striatal-enriched tyrosine phosphatase (STEP)
Steven P. Braithwaite et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
PTEN, a negative regulator of P13 kinase signalling, alters tau phosphorylation in cells by mechanisms independent of GSK-3
Fiona Kerr et al.
FEBS LETTERS (2006)
Crystal structures and inhibitor identification for PTPN5, PTPRR and PTPN7: a family of human MAPK-specific protein tyrosine phosphatases
J Eswaran et al.
BIOCHEMICAL JOURNAL (2006)
PRL tyrosine phosphatases regulate Rho family GTPases to promote invasion and motility
JJ Fiordalisi et al.
CANCER RESEARCH (2006)
Functional studies of protein tyrosine phosphatases with chemical approaches
ZY Zhang
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: Role of Gab1 and Shp2
UGB Haider et al.
MOLECULAR PHARMACOLOGY (2005)
Redox redux: Revisiting PTPs and the control of cell signaling
NK Tonks
CELL (2005)
Visualizing the mechanical activation of Src
YX Wang et al.
NATURE (2005)
Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology
RJ Griffin et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Phosphorylation of tau by fyn: Implications for Alzheimer's disease
G Lee et al.
JOURNAL OF NEUROSCIENCE (2004)
Redox regulation of PTEN and protein tyrosine phosphatases in H2O2-mediated cell signaling
SH Cho et al.
FEBS LETTERS (2004)
Src in synaptic transmission and plasticity
LV Kalia et al.
ONCOGENE (2004)
Eyes absent represents a class of protein tyrosine phosphatases
JP Rayapureddi et al.
NATURE (2003)
PTP1B: From the sidelines to the front lines!
NK Tonks
FEBS LETTERS (2003)
The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
BG Neel et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
Positive and negative regulation of T-cell activation through kinases and phosphatases
T Mustelin et al.
BIOCHEMICAL JOURNAL (2003)
Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis
P Delobel et al.
JOURNAL OF NEUROCHEMISTRY (2002)
The SHP-2 tyrosine phosphatase: Signaling mechanisms and biological functions
CK Qu
CELL RESEARCH (2000)
The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease
XL Ding et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Residue 259 is a key determinant of substrate specificity of protein-tyrosine phosphatases 1B and α
GH Peters et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases
LW Li et al.
SEMINARS IN IMMUNOLOGY (2000)
分享论文
